Company / Depreciation & Amortization
Syndax Pharmaceuticals Inc Depreciation & Amortization History
FY2016-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$90.0K
FY2021
5-year range
$90.0K / $90.0K
FY2017-FY2021
Trend
-
vs FY2020
Sector context
#161 of 168
Health Care
What the data says
Among 168 Health Care companies, Syndax Pharmaceuticals Inc is in the top 4% for depreciation & amortization.
Based on SEC 10-K filings.
$90,000 in FY2021 with a 5-year CAGR of +43.1%.
Remained stable around $90,000 over the past 3 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +0.4%
- 5-Year CAGR
- +43.1%
- 10-Year CAGR
- -
Sector benchmark
Top 4% in Health CareTop 4% of 168This company $90.0K Sector average $212.9M
▼
-100.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +43.1%, indicating consistent growth.
- Ranks #161 out of 168 companies in the Health Care sector.
- Lowest depreciation & amortization in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.08 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $90.0K | - |
| FY2020 | - | - |
| FY2019 | $76.0K | -14.6% |
| FY2018 | $89.0K | +323.8% |
| FY2017 | $21.0K | +40.0% |
| FY2016 | $15.0K | -28.6% |
As of FY2021 · SEC 10-K · Updated Jun 30, 2026